Cited 9 times in
Compared to serum triglyceride alone, the association between serum triglyceride to high-density lipoprotein cholesterol ratio and 10-year cardiovascular disease risk as determined by Framingham risk scores in a large Korean cohort
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김지혜 | - |
dc.date.accessioned | 2022-09-14T01:31:09Z | - |
dc.date.available | 2022-09-14T01:31:09Z | - |
dc.date.issued | 2021-09 | - |
dc.identifier.issn | 0009-8981 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/190492 | - |
dc.description.abstract | Background: The incidence of cardiovascular disease (CVD) has gradually increased to the extent that it has become the most common cause of mortality worldwide, and triglyceride/high-density lipoprotein cholesterol (TG/HDL) ratio, a surrogate marker of insulin resistance, has emerged as an independent predictor of CVD. Additionally, several recent studies have reported an independent association between triglyceride-rich lipoproteins and CVD risk. The present study was conducted to investigate the association between the CVD risk determined by the Framingham risk score and the TG alone and TG/HDL ratio in a large Korean cohort. Methods: This cross-sectional study included 6,995 participants aged 30 to 69 years that participated in a health examination program. TG/HDL ratio quartiles and TG quartiles were categorized as follows: Q1: ≤ 1.25, Q2: 1.26-2.07, Q3: 2.08-3.48, and Q4: ≥3.49; Q1: ≤ 71, Q2: 72-105, Q3: 106-159, and Q4: ≥160, respectively. Odds ratios (ORs) and 95% confidence intervals (CI) for high Framingham 10-year CVD risk (≥10%) were calculated across TG/HDL ratio quartiles and TG quartiles using multiple logistic regression analysis after adjusting for confounding variables. Results: The mean values of most cardiometabolic variables including body mass index, blood pressure, fasting plasma glucose levels, leukocyte count, median CRP levels, and Framingham 10-year CVD risk scores increased gradually with TG/HDL ratio quartiles. The OR (95% CI) of the highest TG/HDL ratio quartile and TG quartile as compared with the lowest TG/HDL ratio quartile and TG quartile for high Framingham 10-year CVD risk was 9.27 (6.68-12.86) and 0.97 (0.69-1.36) after adjusting for confounding variables, respectively. Conclusion: Compared to TG, the TG/HDL ratio was found to be positively and independently associated with Framingham 10-year CVD risk in a large Korean cohort. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Elsevier | - |
dc.relation.isPartOf | CLINICA CHIMICA ACTA | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Cardiovascular Diseases* / epidemiology | - |
dc.subject.MESH | Cholesterol, HDL | - |
dc.subject.MESH | Cross-Sectional Studies | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Republic of Korea / epidemiology | - |
dc.subject.MESH | Risk Factors | - |
dc.subject.MESH | Triglycerides | - |
dc.title | Compared to serum triglyceride alone, the association between serum triglyceride to high-density lipoprotein cholesterol ratio and 10-year cardiovascular disease risk as determined by Framingham risk scores in a large Korean cohort | - |
dc.type | Article | - |
dc.contributor.college | Others | - |
dc.contributor.department | Dept. of Health Promotion (건강의학과) | - |
dc.contributor.googleauthor | Hyang-Rae Lee | - |
dc.contributor.googleauthor | Jong-Koo Kim | - |
dc.contributor.googleauthor | Ji-Hye Kim | - |
dc.contributor.googleauthor | Tae-Ha Chung | - |
dc.identifier.doi | 10.1016/j.cca.2021.05.029 | - |
dc.contributor.localId | A05620 | - |
dc.relation.journalcode | J00543 | - |
dc.identifier.eissn | 1873-3492 | - |
dc.identifier.pmid | 34058221 | - |
dc.identifier.url | https://www.sciencedirect.com/science/article/pii/S0009898121001856 | - |
dc.subject.keyword | Cardiovascular disease | - |
dc.subject.keyword | Insulin resistance | - |
dc.subject.keyword | TG | - |
dc.subject.keyword | TG/HDL ratio | - |
dc.contributor.alternativeName | Kim, Ji-Hye | - |
dc.contributor.affiliatedAuthor | 김지혜 | - |
dc.citation.volume | 520 | - |
dc.citation.startPage | 29 | - |
dc.citation.endPage | 33 | - |
dc.identifier.bibliographicCitation | CLINICA CHIMICA ACTA, Vol.520 : 29-33, 2021-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.